• Aucun résultat trouvé

Monitoring and Evaluation

N/A
N/A
Protected

Academic year: 2022

Partager "Monitoring and Evaluation"

Copied!
13
0
0

Texte intégral

(1)

Monitoring and Evaluation of

Breast Health Initiative

Dr Somesh Kumar

Sr Director, Technical Leadership and Innovations

Jhpiego

(2)

Breast Health

Initiative

(3)

Theory of Change

(4)

Performance Indicators

(5)

Input Indicators

Indicators Target

Proportion of targeted ASHAs/USHAs trained on breast

health awareness 80%

Proportion of targeted service providers trained on

clinical breast examination (CBE) 80%

Proportion of targeted MOs trained on clinical breast examination (CBE) & benign breast

conditions/treatment

80%

Proportion of targetted Specialists trained on Imaging,

Pathology & Procedures (Biopsy ) As per actual Proportion of data handlers trained on data recording,

reporting and compiling 80%

# of state technical advisory group meetings held As per actual

# of learning resource packages developed 3

# of trainers trained through ToTs As per actual

Process Indicators

Indicators Target

Median time taken by women from

nomination by CHW to CBE As per actual Median time taken by women from CBE till

reaching the diagnostic centre As per actual Median time taken by women from reaching

the diagnostic centre to diagnostic evaluation

As per actual Median time taken by women from

diagnostic evaluation to initiation of treatment

As per actual Median time taken by women from

initiation of treatment to completion of treatment

As per actual

Key Performance Indicators (KPI)

(6)

Output Indicators

Indicators Target

Percentage of operational targeted facilities

for early detection of breast cancer (CBE) 80%

Percentage of operational targeted facilities

for diagnostic evaluation of breast cancer 80%

Proportion of ASHA/USHA who have

conducted enumeration of target population 80%

Proportion of women who come to health

facility for CBE 20%

Average number of CBEs performed per

facility As per actual

Outcome Indicators

Indicators

Proportion of women referred for diagnostic evalution after CBE

Proportion of women who underwent diagnostic evaluation

Proportion of women who were confirmed to have breast cancer through diagnostic evaluation

Median size of breast lump of the women who are confirmed to have breast cancer

Proportion of women who need to receive treatment for breast cancer

Proportion of confirmed cases initiated treatment Proportion of confirmed cases completed treatment

Key Performance Indicators (contd)

(7)

Measurement Tools

(8)

Tools

Recording: Enumeration Format, NPCDCS Screening register, CBE positive register, Diagnostic Register, Treatment Register

Reporting : Monthly Reporting format

Referral: Client referral slip, Client card

Processes

(9)

Data Quality Assurance

• Data quality was closely monitored for each data collection/activity tracking process. Data collection was planned in a way that quality is ensured and checked at various points of the data collection and compilation process.

Data quality assurance steps:

✓ Development of standardised data tool with inputs from experts .

✓ Field testing of tool

✓ All data collectors will be oriented in a standardised manner.

✓ Data entry will be done in formats with data validation checks/restrictions

✓ 5-10% of data entered will be crosschecked for inconsistencies

✓ Triangulation of data with different sources

✓ Regular monitoring visits

(10)

Learnings: Regular sharing of dashboard improves program performance

Numbers

1 53

Rakesh.Singh@jhpiego.org

Numbers %

Enumeration 58027

CBE by Facility 7551 13% MPR

CBE +Ve by Facility 829 11% MPR

Went to Diagnostic of Facilities

women excluded VAB 269 32% 64 VAB

Drop Out 560 68%

Total reached to diagnostic 333 40%

CBE +Ve by Diagnostic 199 60%

USG Done 111 56% 88

Mammography 0 0%

FNAC/ FNAB done 6 5% 105

Biopsy done 5 5%

Referred to cancer treatment centre 6 5%

Drop Out Reasons no. of

reasons % Drop Out

Upcoming Week 224 42%

Unable to track 121 23%

Family issues 1 0%

Denied to go to hospital 5 1%

went Medical college/ Private hospital 33 6%

Others (new Cses) 152 28%

Total 536

Breast Health Dashboard of Uttar Pradesh

148 181 364

922

1615

129 108 273

654

1164 87%

60%

75% 71% 72%

0%

20%

40%

60%

80%

100%

0 500 1000 1500 2000

Doctor SN ANM ASHA Total

Training

Available Staff Trained Staff % Trained

25 20 10 15

5

0

% Cumulative +ve CBE findings

Total +ve CBE-829 Total women came to facility for CBE-7551

11%

Oct-18 to May-19

494, 31% 146, 9%

103, 7%

41, 3%

78, 5%

75, 5%

87, 5%

413, 26%

141, 9%

By Facility +ve CBE Finding Lump or thickening inside Swelling, warmth, redness Change in size, shape Dimpling or puckering of skin Itchy, scaly sore Pulling in of nipple Nipple discharge

New pain persistent in one spot No of CBE+ve women followed-up no.=829

58%

5% 3%

2%

0% 2%

3%

24%

3%

Diagnostic +ve CBE Finding no.=194

% Women came to facility

13

%

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

20%

Total Enumeration

58027

285 359

738 837 916 1146

967

2303

31 47 62 103 146 166 88 186

10.9%

13.1%

8.4%

12.3%

15.9%

14.5%

9.1% 8.1%

0%

2%

4%

6%

8%

10%

12%

14%

16%

18%

0 500 1000 1500 2000 2500

Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19

Month wise +Ve CBE Finding

No of women who came to facility for CBE No of women with +ve CBE findings % +Ve CBE

920

1399

350 462

682 598 764 826

300

832

418

110 121 59 53 71 63 44 58 159 66 25

12% 9% 17%

11% 10% 11% 6% 7%

53%

8% 6%

0%

10%

20%

30%

40%

50%

60%

70%

80%

0 200 400 600 800 1000 1200 1400 1600

Facilities wise +Ve CBE Finding

No of women who came to facility for CBE No of women with +ve CBE findings % +Ve CBE No of women

who came to facility for CBE

No of women with +ve CBE findings and referred to diagnostic

centre

women reached to diagnostic

facility

No of women with +ve CBE findings at diagnostic

facility

No of women with +ve CBE findings have undergone

diagnostic evaluation

No of women with +ve CBE

having confirmed carcinoma breast

7551 829 333 199 111 8

13% 11% 40% 60% 56% 7%

(11)

India BHI (by end of 2020) –NOT TO BE SHARED, UNDER PUBLICATION

Women enumerated by

CHWs

Women came to facility for CBE.

Women with +ve CBE findings referred

to diagnostic facility.

Women reached diagnostic facility.

Women found to have +ve CBE findings at diagnostic

facility.

Women underwent diagnostic evaluation.

Women confirmed to have breast cancer.

42

%

68

% 65

% 42

4% % 6%

108,112 45,854 2,053 857 557 379 22 19

Women initiated treatment.

86

%

(12)

No. of CBE: 3247 No. of CBE +Ve: 524

Learnings: Supportive Supervision Visits improve performance NOT TO BE SHARED, UNDER PUBLICATION

• Frequency of supportive supervision visits based on prioritization of facilities.

• The 25 facilities which received frequent supportive supervision

visits (>5) showed improvement in CBE screening as per MPR data.

(13)

Références

Documents relatifs

• Ceci ne veut pas dire que vous soyez d’accord avec ce qu’on vous dit, mais bien que vous. comprenez ce qui

Un point de départ atrial droit associé à un mode de propagation péricardique plaidait en faveur de deux étiologies principales : l’angiosar- come cardiaque (tumeur maligne

Les FC prédo- minent pour 60 % sur la coronaire droite et se jettent dans 90 % des cas dans le tractus cardiaque droit, avec par ordre de fréquen- ce, le ventricule droit,

Fig. 3: Adrenal MRI, postcontrast T1 weighted images. Tous droits réservés.. Quel est votre diagnostic ? 1083.. niques évocateurs de lymphome B comme la fièvre ou les sueurs

quelle place pour l'imagerie en coupes dans le diagnostic actuel de la maladie de Whipple.

Les ponts myocardiques sont superficiels et plutôt apicaux dans 75 % des cas (les fibres musculaires formant le PM sont alors perpendiculaires à l’artère ou la croisent avec un

Localise´e a` l’aire coccygienne, sans irradiation et augmente´e par la station assise et au relever, la douleur peut eˆtre e´galement exacerbe´e par le de´cubitus dorsal

L’ostéite condensante des sacro-iliaques est l’une des causes rares de douleur lombaire et de la hanche (0,9-2,5%) [1, 2], et affecte particulièrement les femmes.. Bien que